The global Urethral Bulking System market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Urinary incontinence is a health issue experienced usually in women. In this condition the patient experience urine leakage due to pressure on urethra and bladder. Thus, frequent urination becomes a significant early symptom. 1 in 3 women at some point of time in their lives suffer from urinary incontinence. Aging increases the chances of urinary incontinence. Urethral incontinence is typically related with the economic burden and affect the quality of life. The treatment for urethral incontinence is usually surgery but with the growing advancement, the ureteral bulking systems has been proved as a better and advanced alternate to open surgery. These bulking systems help to resist the frequent urine flow. The bulking agents are injected in the periurethral wall and then solidifies to cover the wall of urethra, restricting the urine flow. Urethral bulking systems are usually made up of silicone beads, collagen, carbon particles, and polytetrafluoroethylene paste. Recently bulkamid, an injectable bulking agent has been proven effective for urethral incontinence.
Urethral Bulking System Market aims to provide a comprehensive presentation of the global market for Urethral Bulking System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urethral Bulking System. Urethral Bulking System Market contains market size and forecasts of Urethral Bulking System in global, including the following market information:
Global Urethral Bulking System Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Endoscopic Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Urethral Bulking System include CR Bard, Merz Aesthetics, Cogentix Medical, Q-Med, ASCENTX MEDICAL, INC., Coloplast Corp., Boston Scientific Corporation and AstraZeneca, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Urethral Bulking System companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Urethral Bulking System Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Urethral Bulking System Market Segment Percentages, by Type, 2022 (%)
- Endoscopic
- Non- Endoscopic
Global Urethral Bulking System Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Urethral Bulking System Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
Global Urethral Bulking System Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Urethral Bulking System Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Urethral Bulking System revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Urethral Bulking System revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- CR Bard
- Merz Aesthetics
- Cogentix Medical
- Q-Med
- ASCENTX MEDICAL, INC.
- Coloplast Corp.
- Boston Scientific Corporation
- AstraZeneca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Urethral Bulking System, market overview.
Chapter 2: Global Urethral Bulking System market size in revenue.
Chapter 3: Detailed analysis of Urethral Bulking System company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Urethral Bulking System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.